India’s Serum Institute applies for emergency authorisation of Oxford-AstraZeneca vaccine ...palestine

samanews - News
India’s Serum Institute applies for emergency authorisation of Oxford-AstraZeneca vaccine
Vaccine manufacturer Serum Institute of India has applied to the Indian government seeking emergency use authorisation of its COVID-19 vaccine, reported The Hindu. The SII, the world’s largest vaccine producer by volume, sought approval from the Drugs Controller General of India, becoming the first local company to do so. Final trials of the vaccine, also known as Covishield, are ongoing among 1,600 participants across the country. The vaccine contains a modified version of the cold-causing adenovirus that was isolated chimpanzees. It was developed in coordination with the University of Oxford and AstraZeneca and has shown 70% efficacy in clinical trials worldwide. “In terms o

Hence then, the article about india s serum institute applies for emergency authorisation of oxford astrazeneca vaccine was published today ( ) and is available on samanews ( palestine ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( India’s Serum Institute applies for emergency authorisation of Oxford-AstraZeneca vaccine )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News